OrganoClick (ORGC) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
13 Jun, 2025Executive summary
Net sales for Q3 2024 were SEK 28.9 million, down 13.7% year-over-year, with EBIT at SEK -3.0 million, reflecting continued challenges in industrial segments but strong growth in consumer brands.
For the first nine months, net sales declined 10.3% to SEK 105.8 million, with EBIT at SEK -3.0 million, and improved cash flow from operating activities at SEK -1.1 million.
Green coatings & maintenance products saw robust 24% sales growth in Q3, while Nonwoven & fiber technologies and Functional wood segments faced double-digit declines.
Financial highlights
Q3 gross margin was 23.0% (23.8% last year); EBIT margin was -10.4% (-8.4%).
Earnings per share for Q3 were SEK -0.05 (-0.04); for Jan–Sep, SEK -0.10 (-0.08).
Cash and cash equivalents at period end were SEK 4.3 million, with a quick ratio of 34.3%.
Net debt/equity ratio increased to 147.3% from 100.8% a year earlier.
Outlook and guidance
Consumer brands are expected to continue growing in 2025, with positive developments in export markets and new customer gains.
Industrial segments, especially Nonwoven & fiber technologies, are likely to remain challenged due to weak restaurant and construction markets.
The company prioritizes returning to sales growth and profitability in 2025.
Latest events from OrganoClick
- Sales fell sharply and losses deepened, but cost cuts aim to restore profitability in 2026.ORGC
Q4 202512 Feb 2026 - Strong growth in sustainable chemicals, positive cash flow, and European expansion drive 2025 outlook.ORGC
ABGSC Investor Days11 Jan 2026 - Sales fell 22% in Q3, but cost cuts and new financing target improved 2026 results.ORGC
Q3 20255 Nov 2025 - Q2 2025 sales dropped 22.7% year-over-year, with losses widening and new funding secured.ORGC
Q2 202518 Jul 2025 - Gross margin rose to 29.1% as EBIT neared breakeven despite a 5.6% sales decline.ORGC
Q2 202413 Jun 2025 - Biobased innovation drives OrganoClick's growth and expansion in European markets.ORGC
ABGSC Investor Days6 Jun 2025 - Sales fell 7.3% as industrial headwinds persisted, but consumer brands expanded retail reach.ORGC
Q1 20256 Jun 2025 - Consumer brands grew over 30% as industrial sales fell, but cash flow improved in 2024.ORGC
Q4 20245 Jun 2025